Status:
COMPLETED
Effects of Cardiorespiratory Rehabilitation on the Right Ventricle in Pulmonary Hypertension
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Pulmonary Hypertension
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Clinical improvement has been demonstrated after cardiorespiratory rehabilitation in patients with pulmonary hypertension. Rehabilitation is therefore now part of the recommendations for good practice...
Eligibility Criteria
Inclusion
- Major patients
- Proven pulmonary hypertension: PAPm ≥ 25mmHg, known PH
- Group 1,3,4 or 5 of the pulmonary hypertension classification
- Clinical stability \> 1 month clinically determined by clinician
- NYHA II or III class
- Signature of informed consent form following appropriate information
- Patient affiliated to the Social Security System
Exclusion
- Associated left heart disease
- Complex congenital heart disease
- Acoustic window which does not allow the echocardiography to be performed correctly
- Permanent cardiac arrhythmia
- NYHA IV class and NYHA I class
- Inability to perform at least a minimal effort on an ergometer
- Unstabilized acute coronary syndrome
- Compensatory heart failure
- Disturbances of ventricular rhythm veins, may not be narrowed.
- Prevalence of high-risk embolic intracardiac thrombus
- Prevalence of high-risk embolic intracardiac thrombus
- Preference of a medium to high abundance peericard-like thinning.
- Venous thromboembolic venous thromboembolic disease (\> 3 months)
- Left ventricular ejector obstruction (severe and/or symptomatic)
- Persons under guardianship, under curatorship, protected by law
- Persons deprived of their liberty
- Pregnant and parturient women
- Major not able or unable to express consent
- Minors
- Inability to perform cardiac rehabilitation
- Modynamic instability
- Follow-up impossible for geographical or psychological reasons
- Inadequate command of the French language
Key Trial Info
Start Date :
June 12 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 5 2020
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT03404492
Start Date
June 12 2018
End Date
July 5 2020
Last Update
August 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Pasteur
Nice, France, 06002